Skip to main navigation Skip to search Skip to main content

A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants with Metabolic Dysfunction-Associated Steatotic Liver Disease who are at Increased Risk of Developing Major Adverse...

Project: Research

Project Details

StatusActive
Effective start/end date04/9/2610/12/27

Funding

  • Lilly USA LLC: $6,604.00